SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

9.44
Delayed Data
As of May 22
 +0.14 / +1.51%
Today’s Change
4.68
Today|||52-Week Range
9.87
+7.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line28.5M9.6M11.0M25.2M
 
 
 
 
 
Depreciation2.9M3.4M860.0K852.0K
 
 
 
 
 
Total Other Cash Flow-609.0K31.0M4.6M5.1M
 
 
 
 
 
Funds From Operations29.6M37.3M16.7M30.8M
 
 
 
 
 
Funds From/For Other Operating Expenses101.0K-6.3M7.2M3.2M
 
 
 
 
 
Net Cash Flow - Operating Activities29.5M43.5M9.5M27.6M
 
 
 
 
 
 
InvestingIncrease In Investments-2.3M-75.0K0.000.00
 
 
 
Decrease In Investments4.7M0.00379.0K0.00
 
 
 
Capital Expenditures0.00-1.1M-324.0K-1.5M
 
 
 
 
Net Assets From Acquisitions -21.3M0.000.000.00
 
 
Other Investing - Uses0.000.000.00-4.8M
 
 
Net Cash Flow Investing-18.8M-1.2M55.0K-6.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00-1.1M161.0K-1.6M
 
 
 
 
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale6.3M3.5M1.7M5.2M
 
 
 
 
 
Common Preferred Redeemed-3.5M-24.8M-12.5M-24.4M
 
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.002.3M0.00
 
 
Other Uses - Financing0.002.3M0.000.00
 
 
Net Cash Flow - Financing2.8M-24.7M-8.4M-20.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash195.0K-45.0K371.0K-175.0K
 
 
 
 
 
 
Net Change In Cash13.4M17.6M1.2M600.0K
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account